As travel resumes and restrictions lift, Aussie travel services company Helloworld (ASX: HLO) is finally getting some time in the spotlight after a couple of less-than-satisfactory years due to Covid. Its financials paint a pleasant picture with Helloworld’s year-to-date (YTD) revenue totalling $41.6 million, up 180% on the prior corresponding period. After an EBITDA loss
Read More
Recently, US President Joe Biden confused Cambodia for Colombia as he thanked the latter’s prime minister for an ASEAN conference hosted in the Southeast Asian country. They may all be potayto-potahto for Biden; but for wastewater treatment solution Fluence (ASX: FLC), the two countries represent distinct projects that are bringing in the money, with Cambodia
Read More
Cannabis company, Little Green Pharma (ASX: LGP) has been growing its market share all while pleasing investors with its latest announcement that it has obtained an Ethics Approval for its proposed Australian-based, multi-site, placebo-controlled ‘SleepWell Study’ where it will be trialling the Company’s LGP Classic CBD 50 cannabis oil medicine and its effectiveness on stress
Read More
Just because something costs less, it doesn’t mean that it won’t be as good as its pricier counterparts. This is the principle that smart shoppers have been living by, which could save them hundreds of dollars by simply buying private label products. These products will always, always be positioned as a cheaper alternative right next
Read More
In rural India, where the fintech infrastructure is still developing, there is a dire need for companies to set up shop with digital payment services. But until that happens, Findi (ASX: FND), formerly Vortiv, is witnessing substantial earnings growth via transaction fees charged throughout their ATM network. With its country-wide ATM rollout with the Central
Read More
The pharma company developing therapies for unmet needs with the use of medicinal cannabinoids and psychedelics, Incannex Healthcare (ASX: IHL), has been on the move recently and has engaged Eurofins Scientific to manufacture the Company’s ReneCann therapeutic topical application drug. Eurofins Scientific, which is a French group of laboratories based out of Luxemburg, is a
Read More
High interest rates have left Aussies in a lurch, postponing their grand purchases and consolidating their debts. A downside of debt consolidation is that you could end up paying a greater interest rate. That’s why people are counting on non-traditional banks, like neo-lender Wisr (ASX: WZR), which provides interest rates based on an individual’s credit
Read More
When it comes to biotech investing, the value opportunities in Australia attract many of the world’s smartest investors. Amongst them, Platinum Asset Management (ASX: PTM) has joined a growing list of institutions taking a substantial stake in a little-known Aussie biotech set to announce hugely-anticipated clinical trial results within the next few months. With more
Read More
The beginning of FY23 has been an appreciable sales period for online education provider KneoMedia (ASX: KNM) so far. The Company had just deployed 40,000 units of Dell Chromebooks linked to the KneoWorld platform into 11 school districts located across New York City. Students across school districts in all five Boroughs now have access to
Read More
When auditors are unable to get around your financial statements for four months, you know something is off big time. But the question on investors’ mind is: how bad is it? Natural beauty and wellness company BWX (ASX: BWX), known for its brands Sukin, Go-To and Mineral Fusion, is yet to disclose. After releasing a
Read More
